Literature DB >> 27836249

Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology.

Tommaso Stroffolini1, Evangelista Sagnelli2, Giovanni Battista Gaeta3, Caterina Sagnelli2, Angelo Andriulli4, Giuseppina Brancaccio3, Mario Pirisi5, Guido Colloredo6, Filomena Morisco7, Caterina Furlan1, Piero Luigi Almasio8.   

Abstract

BACKGROUND: Previous cross-sectional studies have shown that hepatitis C virus (HCV) infection had been the main agent associated with liver cirrhosis in Italy. AIM: To assess epidemiological, laboratory and clinical features of liver cirrhosis in Italy in 2014. PATIENTS: Out of the 2557 consecutive subjects evaluated in 16 hospitals located throughout Italy in 2014, 832 (32.6%) had liver cirrhosis and were enrolled in this study.
RESULTS: The mean age of subjects was 60.3years, with a male/female ratio of 1.7; 74.9% of cases had Child A cirrhosis and 17.9% superimposed hepatocellular carcinoma. HCV infection, alone or in combination with other aetiologic agents, was responsible of 58.6% of cases, HBV aetiology accounted for the 17.6% and alcohol abuse for the 16.0%. Compared with virus-related cirrhotic patients, those alcohol-related more frequently showed decompensation (p=0.02).
CONCLUSIONS: Compared to previous surveys performed in 1992 and in 2001, we observe a statistically significant (p<0.05) decreasing role of both HCV infection and alcohol abuse as aetiologic agents of liver cirrhosis in Italy, explaining, at least in part, the slow, progressive decline of the mortality rate for liver cirrhosis in the last decades in this country (from 34.5 deaths/100,000 inhabitants in1980 to 10.8 in 2012).
Copyright © 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol abuse; HBV; HCV; Liver cirrhosis; Liver cirrhosis epidemiology

Mesh:

Year:  2016        PMID: 27836249     DOI: 10.1016/j.ejim.2016.10.012

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  10 in total

1.  Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

Authors:  Evangelista Sagnelli; Tommaso Stroffolini; Caterina Sagnelli; Mario Pirisi; Sergio Babudieri; Guido Colloredo; Maurizio Russello; Nicola Coppola; Giovanni Battista Gaeta; Bruno Cacopardo; Massimo De Luca; Piero Luigi Almasio
Journal:  Infection       Date:  2017-11-17       Impact factor: 3.553

2.  Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data.

Authors:  Ugo Fedeli; Enrico Grande; Francesco Grippo; Luisa Frova
Journal:  World J Gastroenterol       Date:  2017-03-14       Impact factor: 5.742

3.  SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.

Authors:  Alessandra Mangia; Valeria Piazzolla; Anna Giannelli; Egidio Visaggi; Nicola Minerva; Vincenzo Palmieri; Immacolata Carraturo; Domenico Potenza; Nicola Napoli; Gianfranco Lauletta; Vincenzo Tagarielli; Rosanna Santoro; Ernesto Piccigallo; Sergio De Gioia; Angelo Chimenti; Giuseppe Cuccorese; Antonio Metrangolo; Michele Mazzola; Ernesto Agostinacchio; Giuseppe Mennea; Carlo Sabbà; Marina Cela; Massimiliano Copetti; Ruggiero Losappio
Journal:  PLoS One       Date:  2019-05-15       Impact factor: 3.240

4.  Prevalence of chronic liver disease among young/middle-aged adults in Northern Italy: role of hepatitis B and hepatitis C virus infection by age, sex, ethnicity.

Authors:  Ugo Fedeli; Francesco Avossa; Eliana Ferroni; Angela De Paoli; Francesco Donato; Maria Chiara Corti
Journal:  Heliyon       Date:  2019-07-18

5.  New landscapes and horizons in hepatocellular carcinoma therapy.

Authors:  Melchiorre Cervello; Maria R Emma; Giuseppa Augello; Antonella Cusimano; Lydia Giannitrapani; Maurizio Soresi; Shaw M Akula; Stephen L Abrams; Linda S Steelman; Alessandro Gulino; Beatrice Belmonte; Giuseppe Montalto; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2020-02-04       Impact factor: 5.682

6.  Child-Turcotte-Pugh Score, MELD Score and MELD-Na Score as Predictors of Short-Term Mortality among Patients with End-Stage Liver Disease in Northern India.

Authors:  Gagandeep Acharya; Rajeev Mohan Kaushik; Rohit Gupta; Reshma Kaushik
Journal:  Inflamm Intest Dis       Date:  2019-11-08

7.  Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.

Authors:  Pierluca Piselli; Diego Serraino; Mario Fusco; Enrico Girardi; Angelo Pirozzi; Federica Toffolutti; Claudia Cimaglia; Martina Taborelli
Journal:  BMC Infect Dis       Date:  2021-07-08       Impact factor: 3.090

8.  Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.

Authors:  Alberto Ferrarese; Giacomo Germani; Martina Gambato; Francesco Paolo Russo; Marco Senzolo; Alberto Zanetto; Sarah Shalaby; Umberto Cillo; Giacomo Zanus; Paolo Angeli; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2018-10-14       Impact factor: 5.742

9.  The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center.

Authors:  Lydia Giannitrapani; Maddalena Zerbo; Simona Amodeo; Elisa Pipitone; Massimo Galia; Tancredi Vincenzo Li Cavoli; Maria Giovanna Minissale; Anna Licata; Cosima Schiavone; Giuseppe Brancatelli; Giuseppe Montalto; Maurizio Soresi
Journal:  Biomed Res Int       Date:  2020-02-27       Impact factor: 3.411

10.  Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort.

Authors:  Anna Licata; Maria Giovanna Minissale; Lydia Giannitrapani; Filippo A Montalto; Clelia Lombardo; Luigi Mirarchi; Simona Amodeo; Maurizio Soresi; Giuseppe Montalto
Journal:  Intern Emerg Med       Date:  2021-04-28       Impact factor: 3.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.